{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T21:21:38Z","timestamp":1697836898160},"reference-count":16,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2007,11,2]],"date-time":"2007-11-02T00:00:00Z","timestamp":1193961600000},"content-version":"vor","delay-in-days":8981,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hematological Oncology"],"published-print":{"date-parts":[[1983,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Out of a series of 427 NHML based on the Kiel classification and without previous treatment, 186 were of high grade malignancy and among them were 83 lymphoblastic (LB) and 58 immunoblastic (IB) lymphomas which were included in this study. The LB and IB, which represent the majority of high grade NHML, were compared regarding their clinical features and courses. Eight main criteria were significantly different between these two groups: age of patient, immunological history, mediastinal and pleural involvement, primary or secondary involvement of the bone marrow, secondary leukaemia, secondary meningeal involvement, and involvement of the facial region. Some of these differences (mediastinum and meningeal involvement) are related to subtypes within LB. The differences between these two groups suggest that different treatment programs may be warranted.<\/jats:p>","DOI":"10.1002\/hon.2900010206","type":"journal-article","created":{"date-parts":[[2010,7,9]],"date-time":"2010-07-09T13:12:23Z","timestamp":1278681143000},"page":"159-163","source":"Crossref","is-referenced-by-count":4,"title":["Distinctive clinical features between lymphoblastic and immunoblastic non\u2010Hodgkin's malignant lymphomas (Kiel's classification) in a series of 141 patients"],"prefix":"10.1002","volume":"1","author":[{"given":"B.","family":"H\u00f3rni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monique","family":"Trojani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Eghbali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Durand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. M.","family":"Coindre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Richaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genevi\u00e8ve","family":"H\u00f3rni\u2010Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Lagarde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,11,2]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1177\/030089167906500209"},{"key":"e_1_2_1_3_1","first-page":"679","article-title":"Les localisations neuro\u2010m\u00e9ning\u00e9es des lymphomes malins non hodgkiniens. A propos de 18 cas observ\u00e9s dans une s\u00e9rie de 370 lymphomes","volume":"13","author":"Bosset J. F.","year":"1980","journal-title":"Bordeaux M\u00e9d."},{"key":"e_1_2_1_4_1","first-page":"222","article-title":"Retrospektive Untersuchungen zur klinischen Bedeutung der Kiel Klassification der malignen Non\u2010Hodgkin\u2010Lymphome","volume":"153","author":"Brittinger G.","year":"1977","journal-title":"Strahlentherapie."},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197711)40:5<2322::AID-CNCR2820400547>3.0.CO;2-9"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1981.tb11616.x"},{"key":"e_1_2_1_7_1","first-page":"129","article-title":"Zur klinischen Relevanz der histologischen Differenzierung maligner Non\u2010Hodgkin\u2010Lymphome nach der \u2018Kiel\u2010Klassification\u2019. Eine retrospektive Studie entsprechender Korrelationnen bei 228 F\u00e4llen aus Schleswig\u2010Holstein","volume":"152","author":"D\u00fchmke E.","year":"1976","journal-title":"Strahlentherapie"},{"key":"e_1_2_1_8_1","first-page":"229","article-title":"Retrospektive Analyse von malignen Non\u2010Hodgkin\u2010Lymphomer\u2010krankungen der Radiologischen Klinik der Universit\u00e4t Kiel von 1969 bis 1975","volume":"153","author":"D\u00fchmke E.","year":"1977","journal-title":"Strahlentherapie"},{"key":"e_1_2_1_9_1","first-page":"479","article-title":"Les lymphosarcomes lymphoblastiques. A propos de 60 malades","volume":"16","author":"H\u0153rni B.","year":"1980","journal-title":"Rev. M\u00e9d. Toulouse."},{"key":"e_1_2_1_10_1","first-page":"627","article-title":"Les lymphosarcomes immunoblastiques. Aspects anatomocliniques et \u00e9volutifs. Analyse r\u00e9trospective d'une s\u00e9rie de 50 malades","volume":"7","author":"H\u0153rni B.","year":"1978","journal-title":"Nouv. Presse M\u00e9d."},{"key":"e_1_2_1_11_1","first-page":"139","article-title":"Lymphomes malins non hodgkiniens. Caract\u00e9res anatomo\u2010cliniques et \u00e9volutifs dans une s\u00e9rie de 370 malades","volume":"67","author":"Lagarde C.","year":"1980","journal-title":"Bull Cancer"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-81092-3"},{"key":"e_1_2_1_13_1","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1182\/blood.V58.1.52.52","article-title":"Immunoblastic sarcoma of T\u2010cell versus B\u2010cell origin: I. Clinical features","volume":"58","author":"Levine S. M.","year":"1981","journal-title":"Blood."},{"key":"e_1_2_1_14_1","first-page":"347","article-title":"Lymphomes malins non hodgkiniens. Etude r\u00e9trospective de 64 cas class\u00e9s selon les nomenclatures de Kiel et de Rappaport","volume":"64","author":"Mandard A. M.","year":"1977","journal-title":"Bull. Cancer"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2964(78)90263-3"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00403365"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1977.1"}],"container-title":["Hematological Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhon.2900010206","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hon.2900010206","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T22:26:08Z","timestamp":1697754368000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hon.2900010206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1983,4]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1983,4]]}},"alternative-id":["10.1002\/hon.2900010206"],"URL":"https:\/\/doi.org\/10.1002\/hon.2900010206","archive":["Portico"],"relation":{},"ISSN":["0278-0232","1099-1069"],"issn-type":[{"value":"0278-0232","type":"print"},{"value":"1099-1069","type":"electronic"}],"subject":[],"published":{"date-parts":[[1983,4]]}}}